期刊文献+

缺血修饰清蛋白对急性冠脉综合征诊断价值的荟萃分析 被引量:7

Diagnosis value of a meta-analysis of ischemia-modified albumin in acute coronary syndrome
下载PDF
导出
摘要 目的系统评价缺血修饰清蛋白(IMA)对急性冠脉综合征(ACS)的诊断价值。方法计算机检索PubMed、Em-base、ScienceDirect、Springer、Ovid、万方、维普等数据库中的文献,按照纳入排除标准筛选文献,采用QUADAS工具评价纳入文献质量,采用SPSS 17.0、Meta-Disc 1.4及Review Manager 4.2进行统计分析。结果最终纳入13篇文献,包括8篇中文文献及5篇英文文献,样本量为2 381例,异质性检验示存在非阈值效应,采用随机效应模型合并统计量。13项研究汇总灵敏度为78%(75%~80%),汇总特异度为66%(63%~68%),汇总阳性似然比为2.57(1.69~3.61),汇总阴性似然比为0.28(0.16~0.48)。SROC曲线下面积为0.848 9。IMA对ACS诊断的灵敏度(72%)高于肌钙蛋白(cTnT)(39%),IMA的特异度(57%)低于cTnT(72%)。结论 IMA对ACS诊断的灵敏度明显高于cTnT,因而可以作为诊断ACS的新指标。同时,IMA值位于正常水平时对排除ACS有更高的临床价值。 Objective To assess the value of ischemia-modified albumin(IMA) in diagnosing acute coronary syndrome.Methods PubMed,Embase,ScienceDirect,Springer,Ovid,WanFang,WeiPu and so on were searched for studies about IMA in the diagnosis of ACS.We screened studies identified for inclusion according to the criteria of inclusion and exclusion.Statistical analysis was performed by SPSS 17.0、Meta-Disc 1.4 and Review Manager 4.2.Results Thirteen studies,including eight Chinese and six English reports,were identified,where 2 381 patients were reported.Heterogeneity test results showed non-threshold effect.Thus,we used the random effect model to combine the data.The pooled sensitivity and specificity of IMA were 78%(75%-80%) and 66%(63%-68%),respectively.The pooled positive and negative likelihood ratios were 2.57(1.69-3.61) and 0.28(0.16-0.48),respectively.The area under the SROC curve(AUC) was 0.848 9.The sensitivity of the IMA(78%) was higher than that of cTnT(39%).By contrast,the specificity of the IMA(57%) is lower than that of cTnT(72%).Conclusion The IMA sensitivity is obviously higher than that of cTnT,which indicated that we could use IMA as a new biomarker of myocardial necrosis to diagnose ACS.Especially,the negative IMA has a high value for excluding ACS.
出处 《国际检验医学杂志》 CAS 2013年第10期1206-1208,1211,共4页 International Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(81171628)
关键词 血清白蛋白 冠状动脉疾病 META分析 serum albumin coronary artery disease Meta-analysis
  • 相关文献

参考文献27

  • 1Burt CW. Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996 [J]. Am J Emerg Med, 1999,17 (6) ; 552-559.
  • 2Pope J H,Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department[J]. N Engl J Med,2000,342(16) :1163 1170.
  • 3Thygesen K, Alpert JS, White HD, et al. Universal definition of the myocardial infarction[J]. Kardiol Pol, 2008,66 (1) : 47-62.
  • 4Sinha MK,Gaze DC,Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention[J. Circulation, 2003,107 (19) : 2403-2405.
  • 5Kim JS, Hwang H J, Ko YG, et al. Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ische mia in real clinical practice[J]. Cardiology,2010,116(2) ;123 129.
  • 6Roy D, Quiles J, Aldama G, et al. Ischemia Modified Albumin for the assessment of patients presenting to the emergency depart- ment with acute chest pain but normal or non-diagnostic 12 lead e- lectrocardiograms and negative cardiac troponin T[J. Int J Cardi- ol, 2004,97 (2) : 297-301.
  • 7Lee YW,Kim HJ,Cho YH, et al. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome[J. Clin Chim Acta, 2007,384(1/2) : 24 27.
  • 8赖泽仁,李凌,金焱.缺血修饰白蛋白在老年急性冠脉综合征诊断中的应用[J].中国老年学杂志,2007,27(13):1267-1269. 被引量:9
  • 9汤天军,张继红,王蒙,闵兴文.缺血修饰白蛋白检测诊断早期急性冠脉综合征[J].广东医学,2007,28(11):1810-1812. 被引量:1
  • 10倪隽,苏建友,鞠少卿,于小红,吴晓晖,王惠民,朱建华.缺血修饰白蛋白在急性冠脉综合征早期诊断中的价值[J].天津医药,2007,35(2):106-107. 被引量:7

二级参考文献64

  • 1关德明,佟滨,焦秀华.急性冠脉综合征的病理学机制[J].哈尔滨医科大学学报,2005,39(1):101-103. 被引量:4
  • 2苏建友,鞠少卿,王惠民,王跃国,朱健华,陈莲英,曹金德,倪隽,尚庆毅.白蛋白钴结合试验测定缺血修饰白蛋白[J].中国交通医学杂志,2005,19(3):210-211. 被引量:23
  • 3陈莉莉,郭小梅,马业新,孙自庸.心型脂肪酸结合蛋白金标记免疫层析法的建立[J].临床检验杂志,2006,24(5):324-325. 被引量:13
  • 4贾克刚,韩雪晶,唐红霞,南芳,张淑菊.应用全自动生化分析仪测定缺血修饰白蛋白[J].检验医学,2007,22(3):320-323. 被引量:21
  • 5Sinha MK,Roy D,Gaze DC,et al. Role of "Ischemia modified albumin",a new biochemical marker of myocardial inchemia, in the early diagnosis of acute coronary syndromes[J]. Emerg Med J, 2004,21 (1):29-34.
  • 6Paul O, Collinson FRCPath, FACB, et al. Biomarkers of cardiovascular Damage and Dysfunction - Ann Overview [J]. Heart, lung and Circulation, 2007,16 : 71-82.
  • 7Roy D,Quihs J,Aldama G,et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T[J]. Int J Cardiol, 2004,97 (2): 297- 301.
  • 8Bhagavan NV,Lai EM,Rios PA,et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[J]. Clin Chem, 2003,49 (4): 581- 585.
  • 9Chan B, Dodswor th N, Woodrow J,et al. Sitespecific N-terminal auto degradation of human .serum albumin [J]. Eur J Bioehem, 1995,227 (1-2):524-528.
  • 10Panteghini M. Role and importance of biochemical markers in clinical cardiology[J]. Eur Heart J,2004,25(14) :1187-1196.

共引文献45

同被引文献63

  • 1贾旭荣,魏向龙.IMA、DNase Ⅰ、H-FABP对急性冠状动脉综合征的早期诊断价值[J].山东医药,2013,53(37):49-50. 被引量:3
  • 2Ramasamy I. Biochemical markers in acute coronary syndrome[J].Clinica Chimica Acta,2011.1279-1296.
  • 3Kehl DW,Iqbal N,Fard A. Biomarkers in acute myocardial injury[J].Translational Research,2012.252-264.
  • 4Sokhanvar S,Mellati AO,Mousavinasab SN. Ischemiamodified albumin (IMA) in differential diagnosis of transient myocardial ischemia from non ischemic chest pain[J].Bratislavske lekarske listy,2012.612-615.
  • 5Dawie J,Chawla R,Worku Y. Diagnosis of ischemic heart disease using CK-MB,troponin-Ⅰ and ischemia modified albumin[J].Ethiopian Medical Journal,2011.25-33.
  • 6Dominguez-Rodriguez A,Abreu-Gonzalez P. Current role of ischemia-modified albumin in routine clinical practice[J].Biomarkers,2010.655-662.
  • 7Oh B J,Seo MH,Kim HS. Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome:discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay[J].Biomarkers,2012.394-401.
  • 8Lu J,Stewart A J,Sadler PJ. Allosteric inhibition of cobalt binding to albumin by fatty acids:implications for the detection of myocardial ischemia[J].Journal of Medicinal Chemistry,2012.4425-4430.
  • 9Luo Y,Wang C,Jiang T. Interference-free determination of ischemia-modified albumin using quantum dot coupled X-ray fluorescence spectroscopy[J].Biosensors and Bioelectronics,2014.136-142.
  • 10Toker A,Aribas A,Yerlikaya FH. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction[J].Journal of Clinical Laboratory Analysis,2013.99-104.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部